From T cells, to the brain, #weightloss and much more, there is no simple unifying one size fits all pathway
Although a trend toward reduced HCC risk was observed, this failed to achieve statistical significance in the overall analysis (IRR: 0.82, 95%CI: 0.61-1.11, P = 0.189), possibly reflecting insufficient follow-up duration to capture the full impact on hepatocarcinogenesis
Unlike certain medications for acne, hair loss, or blood thinning, GLP-1 receptor agonists are not currently on the medication deferral list
You cannot switch medications on your own without medical guidance
December 2025 brought FDA approval for the oral version, designed for adults with obesity or overweight who also have at least one connected health issue
Postgrad Med J 72(843):4550